Type 1 diabetes research: Newer approaches and exciting developments.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 2812749)

Published in Int J Diabetes Dev Ctries on April 01, 2009

Authors

C B Sanjeevi1

Author Affiliations

1: Karolinska Institutet, Diabetes and Endocrinology Division, Molecular Immunogenetics Group at Center for Molecular Medicine; Department of Molecular Medicine and Surgery, Karolinska Hospital, Building L5:01, S-17176 Stockholm, Sweden.

Articles cited by this

Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet (2009) 16.53

Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science (2009) 16.35

Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet (2009) 10.02

GAD treatment and insulin secretion in recent-onset type 1 diabetes. N Engl J Med (2008) 5.74

Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci U S A (1994) 3.77

CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J Immunol (1997) 2.89

The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Ann N Y Acad Sci (2008) 2.65

B cell immunobiology in disease: evolving concepts from the clinic. Annu Rev Immunol (2006) 2.49

Rituximab: expanding role in therapy for lymphomas and autoimmune diseases. Annu Rev Med (2004) 1.66

Type 1 Diabetes TrialNet--an international collaborative clinical trials network. Ann N Y Acad Sci (2008) 1.44

The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties. Eur J Immunol (1993) 1.44

B-cells promote intra-islet CD8+ cytotoxic T-cell survival to enhance type 1 diabetes. Diabetes (2008) 1.12

Approaches in type 1 diabetes research: A status report. Int J Diabetes Dev Ctries (2009) 1.08

B cells in autoimmune diabetes. Rev Diabet Stud (2005) 0.93

The effect of aglycosylation on the immunogenicity of a humanized therapeutic CD3 monoclonal antibody. Transplantation (1995) 0.87